foxo4-dri peptide senolytic animal model 2023 UK | Research FOXO4 - an overview |
FOXO4 an overview ScienceDirect Topics Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI alleviates RIPF. (A) Representative Western blot for the Download Scientific Diagram The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv
Pay in 4 interest-free payments of $6.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22




